Medeva BV v The Comptroller General of Patents

Core Citations

COMMENTS

• Takeda Chemicals Ltd v Comptroller General of the Patent Office

REFERS TO

• Astellas Pharma Inc. v Comptroller General of Patents
• Gilead Sciences Inc. v UK Intellectual Property Office

CONSIDERS

• Takeda Chemicals Ltd v Comptroller General of the Patent Office

CONSIDERS

• Patents Act 1977 - Articles : S-97

CONSIDERED in

• Medeva BV v The Comptroller General of Patents
• (1) Sandoz Ltd v (1) G.D. Searle LLC
• Medimmune Ltd v Novartis Pharmaceuticals UK Ltd and Another

REPORTED OPINION OF in

• 2010 RPC 20
• [2010] 112 BMLR 126
• [2010] Bus LR Digest 102

REFERRED in

• Teva UK Ltd Accord Healthcare Ltd Lupin Ltd and Lupin Europe Ltd Generics (UK) Ltd Trading as Mylan v Gilead Sciences Inc.

This document cites

• Astellas Pharma Inc. v Comptroller General of Patents
• Takeda Chemicals Ltd v Comptroller General of the Patent Office
• Gilead Sciences Inc. v UK Intellectual Property Office
• Takeda Chemicals Ltd v Comptroller General of the Patent Office
• Patents Act 1977



See all quotations

• Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products